110 results
424B5
LYEL
Lyell Immunopharma, Inc.
6 May 24
Prospectus supplement for primary offering
8:12am
grant under our 2021 Equity Incentive Plan;
up to an aggregate of 3,461,629 shares of common stock available for future grant under our 2021 Employee … of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent
S-3
EX-1.2
nek52h4mbhf9sb5v86
28 Feb 24
Shelf registration
7:49pm
S-3
EX-4.5
g5yttkj35lrs95qq
28 Feb 24
Shelf registration
7:49pm
S-3
6uuwqaazc
28 Feb 24
Shelf registration
7:49pm
S-8
EX-5.1
cko54q1sr8cd3pkcsz
28 Feb 24
Registration of securities for employees
7:40pm
S-8
fdvmganqw5s ut
28 Feb 24
Registration of securities for employees
7:40pm
S-8
EX-23.2
wkbdhgn3b re
28 Feb 24
Registration of securities for employees
7:40pm
S-8
8h0s9vqni4 td
28 Feb 24
Registration of securities for employees
7:40pm
8-K
EX-99.1
klez27whtz2 2a
28 Feb 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
4:07pm
8-K
n0ee9
20 Nov 23
Departure of Directors or Certain Officers
4:26pm